Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takumi Shiraishi

Showing results (1-10 of 104) with videos related to

Pageof 11
Sort By:
Current Opinion in Urology|August 14, 2018
Current status and progress of focal therapy in AsiaTakumi Shiraishi, Osamu Ukimura
International Journal of Urology : Official Journal of the Japanese Urological Association|July 18, 2018
Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological AssociationTakumi Shiraishi, Terukazu Nakamura, Osamu Ukimura, et al.
Molecular Cancer|September 26, 2013
Cancer: tilting at windmills?Prakash Kulkarni, Takumi Shiraishi, Rahul V Kulkarni
Asian Journal of Andrology|February 21, 2012
Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancerTakumi Shiraishi, Robert H Getzenberg, Prakash Kulkarni
Angewandte Chemie (International Ed. in English)|July 28, 2017
Reversible Interconversion between 2,5-Dimethylpyrazine and 2,5-Dimethylpiperazine by Iridium-Catalyzed Hydrogenation/Dehydrogenation for Efficient Hydrogen StorageKen-Ichi Fujita, Tomokatsu Wada, Takumi Shiraishi
Oncology Reports|October 9, 2013
Tumor necrosis factor receptor associated factor-4: an adapter protein overexpressed in metastatic prostate cancer is regulated by microRNA-29aFozia Ahmed, Takumi Shiraishi, Robert L Vessella, et al.
IJU Case Reports|January 4, 2021
Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinomaToru Matsugasumi, Hiroyuki Nakanishi, Tomohiro Yokota, et al.
Oncology Reports|October 5, 2007
Glycosylation modulates TRAIL-R1/death receptor 4 protein: different regulations of two pro-apoptotic receptors for TRAIL by tunicamycinTatsushi Yoshida, Takumi Shiraishi, Mano Horinaka, et al.
Molecular Cancer Therapeutics|May 2, 2006
The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligandMano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, et al.
International Journal of Clinical Oncology|June 17, 2008
Current trends in diagnostic and therapeutic principles for prostate cancer in JapanKoji Okihara, Takumi Shiraishi, Osamu Ukimura, et al.
Pageof 11

Showing results (1-10 of 104) with videos related to

Sort By:
Pageof 11
Current Opinion in Urology|August 14, 2018
Current status and progress of focal therapy in AsiaTakumi Shiraishi, Osamu Ukimura
International Journal of Urology : Official Journal of the Japanese Urological Association|July 18, 2018
Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological AssociationTakumi Shiraishi, Terukazu Nakamura, Osamu Ukimura, et al.
Molecular Cancer|September 26, 2013
Cancer: tilting at windmills?Prakash Kulkarni, Takumi Shiraishi, Rahul V Kulkarni
Asian Journal of Andrology|February 21, 2012
Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancerTakumi Shiraishi, Robert H Getzenberg, Prakash Kulkarni
Angewandte Chemie (International Ed. in English)|July 28, 2017
Reversible Interconversion between 2,5-Dimethylpyrazine and 2,5-Dimethylpiperazine by Iridium-Catalyzed Hydrogenation/Dehydrogenation for Efficient Hydrogen StorageKen-Ichi Fujita, Tomokatsu Wada, Takumi Shiraishi
Oncology Reports|October 9, 2013
Tumor necrosis factor receptor associated factor-4: an adapter protein overexpressed in metastatic prostate cancer is regulated by microRNA-29aFozia Ahmed, Takumi Shiraishi, Robert L Vessella, et al.
IJU Case Reports|January 4, 2021
Prostate squamous cell carcinoma developing 11 years after external radiotherapy for prostate adenocarcinomaToru Matsugasumi, Hiroyuki Nakanishi, Tomohiro Yokota, et al.
Oncology Reports|October 5, 2007
Glycosylation modulates TRAIL-R1/death receptor 4 protein: different regulations of two pro-apoptotic receptors for TRAIL by tunicamycinTatsushi Yoshida, Takumi Shiraishi, Mano Horinaka, et al.
Molecular Cancer Therapeutics|May 2, 2006
The dietary flavonoid apigenin sensitizes malignant tumor cells to tumor necrosis factor-related apoptosis-inducing ligandMano Horinaka, Tatsushi Yoshida, Takumi Shiraishi, et al.
International Journal of Clinical Oncology|June 17, 2008
Current trends in diagnostic and therapeutic principles for prostate cancer in JapanKoji Okihara, Takumi Shiraishi, Osamu Ukimura, et al.
Pageof 11